ELEVATED SERUM PROGESTERONE LEVELS ON THE DAY OF HUMAN CHORIONIC-GONADOTROPIN ADMINISTRATION IN IN-VITRO FERTILIZATION CYCLES DO NOT ADVERSELY AFFECT EMBRYO QUALITY
Km. Silverberg et al., ELEVATED SERUM PROGESTERONE LEVELS ON THE DAY OF HUMAN CHORIONIC-GONADOTROPIN ADMINISTRATION IN IN-VITRO FERTILIZATION CYCLES DO NOT ADVERSELY AFFECT EMBRYO QUALITY, Fertility and sterility, 61(3), 1994, pp. 508-513
Objective: To assess the effect of an elevated serum P level on the da
y of hCG administration in an IVF cycle on resulting embryos by evalua
ting their performance at subsequent frozen ET. Design: A retrospectiv
e study. Participants: Ninety-six consecutive patients undergoing froz
en ET cycles were studied in a tertiary care center. Main Outcome Meas
ures: Serum obtained on the day of hCG administration in an IVF cycle
was assayed for E(2) and P by RIA. The main outcome measured was the d
evelopment of a clinical pregnancy in a subsequent frozen ET cycle. Re
sults: Using a previously described breakpoint in serum P concentratio
n of 0.9 ng/mL (2.86 nmol/L), 8 of 69 (11.6%) frozen ETs in which embr
yos from low P level IVF cycles were transferred and 7 of 27 (25.9%) f
rozen ETs of embryos from elevated P level IVF cycles were transferred
resulted in the development of clinical pregnancies. Although this do
es not clearly demonstrate superiority of embryos obtained from elevat
ed P cycles, employing a power calculation, the probability that the p
regnancy rate in the elevated serum P group is at least equal to the o
bserved rate in the low P group is 92.8%.